Observational Cohort Study on Ocular Chronic Graft-Versus-Host Disease
NCT07794800 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 340
Last updated 2026-08-31
Summary
This study is a multicenter, prospective, observational cohort study designed to enroll a total of 340 patients undergoing allogeneic hematopoietic stem cell transplantation. Through comprehensive evaluations by hematology departments, ophthalmology departments, and patient-reported outcomes, the study aims to assess patient-reported outcomes, overall incidence, risk factors, and other clinical outcomes in patients with chronic ocular graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Conditions
- Chronic Graft Versus Host Disease in Eye
Sponsors & Collaborators
-
Ruijin Hospital
lead OTHER
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-06-01
- Primary Completion
- 2030-06-01
- Completion
- 2030-06-01
Countries
- China
Study Locations
More Related Trials
-
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
NCT00550498 ·Status: TERMINATED ·Phase: PHASE1
-
Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders
NCT07381738 ·Status: RECRUITING ·Phase: PHASE2
-
Immune Response to Vaccinations in Hematopoietic Stem Cell Transplant Recipients
NCT03659773 ·Status: COMPLETED ·Phase: NA
-
A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease
NCT02923375 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation.
NCT04222023 ·Status: COMPLETED ·Phase: PHASE4
-
CMV Infection and Immune Intervention After Transplantation
NCT04320303 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT
NCT06491719 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
HCMV-miRNA Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation Using PSTM-qPCR
NCT07210242 ·Status: NOT_YET_RECRUITING
-
Belumosudil Versus Ruxolitinib for Steroid-Refractory or Breakthrough Hepatic cGVHD
NCT07794514 ·Status: RECRUITING ·Phase: NA
-
Abatacept s.c. for aGVHD Prevention in Haplo-HCT
NCT04686929 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
BPC2001 for the Prevention of Acute Graft-Versus-Host Disease Following Haploidentical Stem Cell Transplantation
NCT07246031 ·Status: RECRUITING ·Phase: PHASE2
-
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
NCT05156710 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
HBV Reactivation Prediction Model in Allo-HSCT
NCT07644026 ·Status: NOT_YET_RECRUITING
-
Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients
NCT04164576 ·Status: NOT_YET_RECRUITING
-
The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)
NCT02804464 ·Status: UNKNOWN
-
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07703657 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Signature of the Host Response to a Respiratory Viral Infection, in the Prediction of Bronchiolitis Obliterans
NCT04099082 ·Status: RECRUITING
-
Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
NCT01569373 ·Status: WITHDRAWN
-
Extracorporeal Photopheresis to Treat Chronic Graft-Versus-Host Disease
NCT00048789 ·Status: COMPLETED ·Phase: PHASE2
-
Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation
NCT06649201 ·Status: RECRUITING
-
Intestinal Microbiome-based Research for the Prevention of Acute GVHD
NCT05808985 ·Status: UNKNOWN ·Phase: PHASE2
-
Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients
NCT04285788 ·Status: COMPLETED
-
Predictive Biomarkers For Pediatric Chronic Graft-Versus-Host Disease
NCT02067832 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease
NCT03653247 ·Status: COMPLETED ·Phase: PHASE1/PHASE2